Clinical Trial Update: Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and efficacy of MK-8521 versus placebo and an active diabetes drug in type 2 diabetes; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MK-8521

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2022-03-08